Key Takeaway
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say. The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be…
Published October 9, 2026 · Category: News
Overview
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label
Women living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.
Details
The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.
Continue reading...
Source
Originally published at www.theguardian.com.
Related Articles
Frequently Asked Questions
What is "Women with PMOS should get subsidised weight loss drugs, advocates say" about?+
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition. Cont
Who reported this story?+
This story was reported by The Guardian World.